Innovative Diagnostics

Since 2004, Innovative Diagnostics develops, produces and sells ELISA, PCR and rapid tests for the clinical and animal health sectors. Located near Montpellier, France, 120 employees work in our vast 4000 m² laboratory facilities. Innovative Diagnostics is an actor of the One Health approach, which recognizes that human health and animal health are interdependent. We help to protect both human health and the global food supply by offering diagnostic tests to detect zoonotic diseases in humans and animals, and veterinary diseases in farm animals. Our tests for zoonotic diseases include COVID-19, Rift Valley Fever, West Nile Fever, Q Fever, Crimea Congo Haemorrhagic Fever, and Bovine Tuberculosis. Our reknown IDvet product line covers major veterinary diseases, which have a significant impact on the food supply in recent years include Foot and Mouth Disease and African Swine Fever. Innovative Diagnostics is independent and 100% self-financed with its own R&D activities and state-of-the art, automated production line, allowing the company to react immediately to sanitary emergencies. With a dynamic R&D department, high quality products, a diverse product portfolio and excellent customer service, Innovative Diagnostics is a rapidly growing company with sales covering over 100 countries. To be ever closer to our clients, Innovative Diagnostics has opened offices in Brazil, India and China, and a production facility in the United States.